Keryx Biopharmaceuticals (KERX) Selloff 'Unwarranted'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Keryx Biopharma (KERX) Pulls-Back After Ripping Over 160% on Zerenex DAta
February 1, 2013 11:54 AM ESTLooks like the ride for Keryx Biopharmaceuticals Inc. (KERX) might be coming to a close.
After moving up 165 percent this week through Thursday, shares of Keryx are retracing a bit today. The stock is down over 15 percent on volume as traders look to cash out on some... More
Keryx Biopharma (KERX) Prices 8.23M Offering at $8.49/Share
January 31, 2013 6:53 AM ESTKeryx Biopharmaceuticals, Inc. (NASDAQ: KERX) announced the pricing of its previously announced underwritten public offering of common stock consisting of 8,234,000 shares at $8.49 per share. In connection with this offering, Keryx granted to the underwriters a 30-day option to purchase 1,235,100 additional shares of... More
